RELMADA THERAPEUTICS, INC. (RLMD) Free cash flow 2016–2020
RELMADA THERAPEUTICS, INC. (RLMD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$209.9MFY2020 · since FY2016: -$6.5M → -$209.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -$209.9M | -116.5% |
| FY2019 | -$96.9M | — |
| FY2017 | -$6.0M | +7.7% |
| FY2016 | -$6.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RLMD financial trends
RLMD RevenueRLMD Net incomeRLMD Net marginRLMD Gross profitRLMD Gross marginRLMD Operating incomeRLMD Operating marginRLMD Operating cash flowRLMD Capital expendituresRLMD Return on equityRLMD Stock buybacksRLMD Dividends paidRLMD Total assetsRLMD Total liabilitiesRLMD Shareholders’ equityRLMD overview →